Sign in

CIK 0001869105 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

BridgeBio Oncology Therapeutics, Inc.

Sign in to watch
Ticker
BBOT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
857 702 0377
Business address
256 E. GRAND AVENUE, SUITE 104, SOUTH SAN FRANCISCO, CA, 94080
Former names
Helix Acquisition Corp. II
  1. 425 Deal Prospectus/Communication re Business Combination
  2. SCHEDULE 13D/A Stake Beneficial Ownership Report
  3. 425 Deal Prospectus/Communication re Business Combination
  4. 8-K Event Material agreement · Unregistered share sale
  5. 425 Deal Prospectus/Communication re Business Combination
  6. 8-K Event Regulation FD disclosure
  7. 3 Insider Initial Statement of Ownership
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 8-K Event Executive or director change
  11. 10-Q Report Quarterly Report
  12. SC 13G Stake Amended Statement of Ownership
  13. SC 13G Stake Amended Statement of Ownership
  14. SC 13G Stake Amended Statement of Ownership
  15. 10-Q Report Quarterly Report
  16. 10-Q Report Quarterly Report
  17. SC 13G Stake Amended Statement of Ownership
  18. SC 13G Stake Amended Statement of Ownership
  19. SC 13D Stake Beneficial Ownership Report
  20. 8-K Event Other events

Page 8 of 10 · 187 filings